Landmarks in clinical renal transplantation.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 4550586)

Published in Surg Gynecol Obstet on February 01, 1972

Authors

C G Groth

Articles by these authors

(truncated to the top 100)

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94

No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 2.91

Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72

Kidney donors live longer. Transplantation (1997) 2.61

Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58

Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg (1968) 2.32

Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23

An everting technique for intraluminal vascular suturing. Surg Gynecol Obstet (1968) 2.12

HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin. Lancet (1986) 2.08

Coagulation during and after orthotopic transplantation of the human liver. Arch Surg (1969) 2.03

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet (1993) 2.00

Infections in recipients of liver homografts. N Engl J Med (1968) 1.92

Urological complications in 216 human recipients of renal transplants. Ann Surg (1970) 1.90

Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83

Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery (1971) 1.79

Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78

Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77

Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74

Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73

Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg (1975) 1.72

Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans. Proc Soc Exp Biol Med (1968) 1.68

Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65

Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation. J Lab Clin Med (1969) 1.63

Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol Suppl (1980) 1.63

Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet (1991) 1.60

Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg (1968) 1.56

Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther (1980) 1.39

Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study. Lancet (1987) 1.38

SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37

Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36

Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med (1968) 1.36

Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc (1977) 1.35

Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Am J Hum Genet (1983) 1.33

Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production. Surgery (1969) 1.29

Studies of cytomegalovirus infection in renal allograft recipients. Scand J Infect Dis (1982) 1.27

Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet (1983) 1.26

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25

Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24

Hypertriglyceridemia in renal transplant recipients treated with sirolimus. Transplant Proc (1998) 1.19

Perspectives in organ transplantation. Antibiot Chemother (1969) 1.19

Experience with human liver grafts obtained after donor cardiac standstill. Transplant Proc (1987) 1.18

Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation (1999) 1.16

Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes (1989) 1.14

Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes (1985) 1.13

Successful outcome of segmental human pancreatic transplantation with enteric exocrine diversion after modifications in technique. Lancet (1982) 1.12

Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology (1992) 1.12

Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol (1972) 1.12

Splenic transplantation in a case of Gaucher's disease. Lancet (1971) 1.12

Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients. Ther Drug Monit (1997) 1.10

Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care (1983) 1.10

Attempted spleen transplant in classical hemophilia. Transplantation (1969) 1.09

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett (2000) 1.08

Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation (1995) 1.07

The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surg Gynecol Obstet (1973) 1.04

Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc (1973) 1.04

Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation (1995) 1.02

Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clin Genet (1982) 1.02

Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes (1989) 1.02

Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease. Transplantation (1988) 1.00

Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin). Transplantation (1998) 0.98

The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet (1973) 0.98

Thymectomy and renal homotransplantation. Clin Exp Immunol (1970) 0.98

Personal experience with orthotopic liver transplantation. Transplant Proc (1972) 0.96

Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients. Br J Clin Pharmacol (1999) 0.96

Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers. Ther Drug Monit (2000) 0.95

Improved results using whole organ pancreatico-duodenal transplants with enteric exocrine drainage. Transplant Proc (1994) 0.94

Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery (1974) 0.94

Urinary tract infections following renal transplantation. Clin Transplant (1998) 0.93

Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation (1999) 0.93

A technique for rapid harvesting of cadaveric renal and pancreatic grafts after circulatory arrest. Br J Surg (1976) 0.92

Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days. Transplantation (2001) 0.92

Rejection of isolated pancreatic allografts in patients with with diabetes. Surg Gynecol Obstet (1976) 0.91

Segmental pancreatic transplantation with duct ligation or drainage to a jejunal Roux-en-Y loop in nonuremic diabetic patients. Diabetes (1980) 0.90

Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation (1995) 0.90

Renal transplantation at the University of Colorado. Transplantation (1967) 0.90

Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90

Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation. Dev Neurosci (1991) 0.89

Immunosuppression with cyclophosphamide in the dog. Clin Exp Immunol (1975) 0.89

The effect of infused albumin and Rheomacrodex on factors governing the flow properties of the human blood. Acta Chir Scand (1966) 0.88

Long-term metabolic control in recipients of segmental-pancreas grafts with pancreaticoenterostomy or duct obstruction. Diabetes (1989) 0.88

Radioisotope scanning in experimental and clinical orthotopic liver transplantation. Surg Gynecol Obstet (1968) 0.88

Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man. Transplant Proc (1992) 0.88

Improved results in pancreatic transplantation by avoidance of nonimmunological graft failures. Transplantation (1987) 0.88

Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type. Acta Paediatr Scand (1990) 0.87

The effect of rheomacrodex and macrodex on factors governing the flow properties of the human blood. Acta Chir Scand (1965) 0.87

Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs. Transplantation (2001) 0.87

Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study. Scand J Infect Dis (1984) 0.86

Blood flow in auxiliary canine liver homografts. J Surg Res (1969) 0.86

Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc (1987) 0.86

Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes (1992) 0.86

Survival of a homologous parathyroid implant in an immunosuppressed patient. Lancet (1973) 0.86

Pancreatic transplantation with enteric exocrine diversion--the Stockholm experience. Transplant Proc (1987) 0.85

Metabolic effects of living related pancreatic graft donation. Transplant Proc (1988) 0.85

Simplifying the technique for pancreaticoduodenal transplantation with enteric exocrine drainage. Transplant Proc (1995) 0.85

Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation (1995) 0.85